Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention

    December 20, 2017

    Clinical question: Can the dual-antiplatelet therapy scoring system be used to determine which patients undergoing percutaneous coronary intervention (PCI) would benefit from prolonged (24 months) DAPT?

  • 1
    News

    Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy

    December 19, 2017

    Clinical question: Is alcohol septal ablation (ASA) safe in younger patients with obstructive hypertrophic cardiomyopathy (HCM)?

  • 1
    News

    Acute kidney injury linked with doubled inpatient VTEs

    December 8, 2017

    TORONTO – Which comes first: the acute kidney injury or the venous thromboembolism?

  • 1
    News

    Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk

    December 6, 2017

    The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.

  • 1
    News

    Underlying peripheral arterial or venous disease in patients with lower extremity SSTIs

    December 5, 2017

    Hospitalists are in a unique position to identify patients with underlying peripheral arterial and venous disease when they are admitted for lower extremity skin and soft tissue infections.

  • 1
    News

    Benefit of dabigatran over warfarin persists in AF patient subgroups undergoing PCI

    December 3, 2017

    ANAHEIM, CALIF. – Dabigatran protected against thromboembolic events with less bleeding regardless of stent type, type of concomitant treatment, or indication for PCI.

  • 1
    News

    Observing BP measurement made no difference in SPRINT

    November 28, 2017

    ANAHEIM, CALIF. – It didn’t matter whether BP measurements were observed or not; blood pressure control and outcomes were largely the same either way.

  • News

    Heart failure readmission penalties linked with rise in deaths

    November 18, 2017

    Heart failure readmissions penalties linked with rise in deaths ANAHEIM, CALIF. – Evidence continues to mount that Medicare’s penalization of hospitals with excess heart failure readmissions has cut readmissions but at the apparent price of more deaths.During the penalty phase of...

  • 1
    News

    Prescribers mostly ignore clopidogrel pharmacogenomic profiling

    November 16, 2017

    ANAHEIM, CALIF. – Physicians treating ACS patients with an antiplatelet all but ignore their genetically assessed ability to metabolize clopidogrel.

  • 1
    News

    Keep PCI patients on aspirin for noncardiac surgery

    November 15, 2017

    ANAHEIM, CALIF. – Perioperative aspirin is more likely to help than harm PCI patients undergoing noncardiac surgery.

Previous1 … 63 64 65 66 67 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences